Announcements
HHS, Janssen Research & Development join forces on innovative influenza products
A public-private partnership announced today between the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Janssen Research & Development LLC, will drive advanced development of an entire portfolio of innovative products to prevent or treat infections caused by emerging infectious diseases, including influenza viruses with pandemic potential...
HHS spurs new antibiotic development for biodefense and common infections
To combat potentially deadly Clostridium difficile infections that can occur in patients being treated for bacterial infections including anthrax, tularemia and other biothreats...
BARDA adds new antibiotic to treat drug-resistant bacterial infections in order to protect the American public
Antibiotics underpin nearly every facet of modern medicine. You can’t have a hip replacement or a caesarean section without effective antibiotics to prevent or treat bacterial infections...
